BETHESDA, Md.--(BUSINESS WIRE)--September 03, 2025-- 

Global Medical REIT Inc. (NYSE: GMRE) (the "Company" or "GMRE") announced today that its Board of Directors ("Board") has declared the Company's 2025 third quarter common and preferred dividends.

Common Dividend

The Board has declared the Company's 2025 third quarter cash dividend of $0.75 per share of common stock and unit (the "Common Dividend"). The Common Dividend is payable on October 15, 2025, to common stockholders and unitholders of record as of September 29, 2025 (the "Record Date"). Because the Record Date for the Common Dividend is after September 19, 2025, the anticipated effective date of the Company's previously announced one-for-five reverse stock split (the "Reverse Stock Split"), the Common Dividend will reflect the Reverse Stock Split and will be paid on a split-adjusted basis. The Common Dividend equates to a dividend of $0.15 per share of common stock on a pre-split basis.

Additional information on the Reverse Stock Split can be found in the August 13, 2025 announcement on the Company's website (announcement link).

Series A Preferred Dividend

The Board has also declared a quarterly cash dividend of $0.46875 per share on its Series A Cumulative Redeemable Preferred Stock, $0.001 par value per share (the "Series A Preferred Stock"), which is payable on October 31, 2025, to Series A Preferred stockholders of record as of October 15, 2025. This represents the Company's quarterly dividend on its Series A Preferred Stock for the period from July 31, 2025 through October 30, 2025.

About Global Medical REIT Inc.

Global Medical REIT Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Additional information on GMRE can be obtained on its website at www.globalmedicalreit.com.

Forward-Looking Statements

Certain statements contained herein may be considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, and it is the Company's intent that any such statements be protected by the safe harbor created thereby. These forward-looking statements are identified by their use of terms and phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "plan," "predict," "project," "will," "continue" and other similar terms and phrases, including references to assumptions and forecasts of future results. Except for historical information, the statements set forth herein including, but not limited to, any statements regarding the Company's expected dividend payments and Reverse Stock Split are forward-looking statements. These forward-looking statements are based on our current expectations, estimates and assumptions and are subject to certain risks and uncertainties. Although the Company believes that the expectations, estimates and assumptions reflected in its forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of the Company's forward-looking statements. Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, and in our other filings with the SEC. You are cautioned not to place undue reliance on forward-looking statements. The Company does not intend, and undertakes no obligation, to update any forward-looking statement.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250903327968/en/

 
    CONTACT:    Investor Relations: 

Email: Investors@globalmedicalreit.com

Phone: 202.524.6869

(END) Dow Jones Newswires

September 03, 2025 16:05 ET (20:05 GMT)